Biosurgery Market Size, Share, Growth Analysis, By Type(Surgical sealants, adhesives) - Industry Forecast 2024-2031


Report ID: SQMIG35G2174 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 38 | Figures: 74

To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Biosurgery Market size was valued at USD 13.89 billion in 2021 and is poised to grow from USD 14.56 billion in 2022 to USD 24.21 billion by 2030, growing at a CAGR of 6.9% in the forecast period (2023-2030).

The biosurgery market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of Biosurgerys. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions. 'Johnson & Johnson (United States)', 'Baxter International Inc. (United States)', 'Medtronic plc (Ireland)', 'Integra LifeSciences Holdings Corporation (United States)', 'B. Braun Melsungen AG (Germany)', 'Stryker Corporation (United States)', 'Ethicon, Inc. (United States)', 'Smith & Nephew plc (United Kingdom)', 'Olympus Corporation (Japan)', 'C.R. Bard, Inc. (United States)', 'Zimmer Biomet Holdings, Inc. (United States)', 'BD (Becton, Dickinson and Company) (United States)', 'Atrium Medical Corporation (United States)', 'Maquet Holding B.V. & Co. KG (Germany)', 'CryoLife, Inc. (United States)', 'Johnson Matthey (United Kingdom)', 'CSL Limited (Australia)', 'Biotime, Inc. (United States)', 'Cohera Medical, Inc. (United States)', 'Sanofi S.A. (France)'

One key driver of the biosurgery market is the increasing demand for minimally invasive surgical procedures. Biosurgery products are often used in minimally invasive surgeries as they offer benefits such as reduced trauma, faster recovery time, and minimal scarring. The growing preference for these procedures among patients and surgeons is driving the demand for biosurgery products. Additionally, advancements in technology, such as the development of innovative biomaterials and surgical sealants, are further propelling the growth of the biosurgery market.

One key market trend in the biosurgery market is the growing adoption of minimally invasive surgical procedures. Minimally invasive techniques offer several advantages over traditional open surgeries, including smaller incisions, reduced scarring, faster recovery time, and decreased postoperative complications. As a result, there is a rising demand for biosurgical products that are specifically designed for use in minimally invasive procedures. This trend is driven by the increasing preference of patients and healthcare providers for less invasive treatments that offer similar or better outcomes. Manufacturers in the Biosurgery market are focusing on developing innovative products and techniques to cater to this growing demand and enhance patient satisfaction.

One dominant region in the biosurgery market is North America. This region has a well-established healthcare infrastructure, advanced surgical techniques, and a high adoption rate of biosurgical products. The presence of key market players and significant investments in research and development activities contribute to the dominance of this region. North America is characterized by a large patient pool, increasing prevalence of chronic diseases, and a growing geriatric population, which drives the demand for biosurgery products and procedures.

Feedback From Our Clients

Global Biosurgery Market

Product ID: SQMIG35G2174

$5,300
BUY NOW